Cargando…
Treating pyruvate kinase deficiency with Mitapivat: a short communication
Autores principales: | Larik, Muhammad Omar, Shiraz, Moeez Ibrahim, Iftekhar, Muhammad Ashhal, Shiraz, Seemin Afshan, Shiraz, Maira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289629/ https://www.ncbi.nlm.nih.gov/pubmed/37363540 http://dx.doi.org/10.1097/MS9.0000000000000759 |
Ejemplares similares
-
Bombay Blood Group Phenotype Misdiagnosed As O Phenotype: A Case Report
por: Qadir, Hira, et al.
Publicado: (2023) -
P1546: ACTIVATE-KIDST: MITAPIVAT IN CHILDREN WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
por: Grace, R. F., et al.
Publicado: (2022) -
P1547: ACTIVATE-KIDS: MITAPIVAT IN CHILDREN WITH PYRUVATE KINASE DEFICIENCY WHO ARE NOT REGULARLY TRANSFUSED
por: Grace, R. F., et al.
Publicado: (2022) -
P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
por: van Beers, E. J., et al.
Publicado: (2022) -
P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
por: van Beers, Eduard, et al.
Publicado: (2023)